non-small cell lung cancer: AstraZeneca's Tagrisso trial results presented - 0 views
-
ramchintamaneni on 22 Oct 19Final results from the Phase III FLAURA trial investigating AstraZeneca's Tagrissofinal reinforce the therapy as the SOC for first-line treatment of patients with EGFRm advanced NSCLC.